Latest news with #PrimaryCare
South Wales Argus
2 hours ago
- Health
- South Wales Argus
Mounjaro and Ozempic warning for holiday travel insurance
The last year has seen a huge increase in the number of people taking GLP-1 receptor agonists, including semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro) and liraglutide (Saxenda). Others may be taking tablets such as Orlistat or Alli. Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately online, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. Do I Need Travel Insurance? "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' 'Skinny Jab' weight loss medication is surging According to The Pharmacist website 1.5 million UK citizens used weight-loss jabs in March 2025, and the number is believed to be growing each month. 'Recent NHS data shows that between March 2024 and February 2025, more than 83,000 unique patients in England were dispensed Ozempic, while over 344,000 people received a prescription for weight-loss medications overall in the past year," says Niraj. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further.' Recommended reading: What to do if you are travelling abroad while taking weight-loss medication Declare all pre-existing medical conditions and any medications, including Ozempic, Wegovy, and Mounjaro, when purchasing travel insurance. If you are taking medication without a prescription or for off-label use, you must disclose this, as it can affect your travel cover. Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs. Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
Glasgow Times
15 hours ago
- Health
- Glasgow Times
Mounjaro and Ozempic warning for holiday travel insurance
The last year has seen a huge increase in the number of people taking GLP-1 receptor agonists, including semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro) and liraglutide (Saxenda). Others may be taking tablets such as Orlistat or Alli. Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately online, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. Do I Need Travel Insurance? "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' 'Skinny Jab' weight loss medication is surging According to The Pharmacist website 1.5 million UK citizens used weight-loss jabs in March 2025, and the number is believed to be growing each month. 'Recent NHS data shows that between March 2024 and February 2025, more than 83,000 unique patients in England were dispensed Ozempic, while over 344,000 people received a prescription for weight-loss medications overall in the past year," says Niraj. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further.' Recommended reading: What to do if you are travelling abroad while taking weight-loss medication Declare all pre-existing medical conditions and any medications, including Ozempic, Wegovy, and Mounjaro, when purchasing travel insurance. If you are taking medication without a prescription or for off-label use, you must disclose this, as it can affect your travel cover. Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs. Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
Irish Independent
30-04-2025
- Health
- Irish Independent
Clarity required from Minister for Health on Kanturk Primary Healthcare Centre
Kanturk received a blow last week with the news that a brand-new primary healthcare centre has been further delayed. The project, which was due to go to construction this time last year, has now seen the developer who had initially won the tender pull out of the project – meaning the HSE will now have to re-tender the Primary Care Centre. The project was due to be developed by Dublin-based Manderley Holdings, who had employed Meitheal Architects to take on the job. The centre had been in planning since February 2018 and had been granted permission in December of that year. The development was set to include medical consulting, treatment, and GP rooms, a mental health facility, an ancillary healthcare professional services suits, along with landscaping works and the inclusion of 21 car parking spaces and one ambulance drop-off point. The proposed Primary Care Centre will now be re-tendered via the HSE's e-tender process, which is expected to start 'in the coming months'. Senator Ryan expressed her frustration with another delay in the long-awaited Kanturk Primary Healthcare Centre. 'The project has suffered a significant setback. It is deeply disappointing and frustrating to learn of yet another delay. This project has been in the pipeline since 2018. The latest setback with the original developer pulling out is yet another blow to the people of Kanturk and the surrounding areas. 'The current situation is unacceptable,' said Ms Ryan. 'The community has been waiting far too long for access to modern accessible healthcare facilities. The HSE must act urgently to re-tender this project and ensure that it proceeds without further delay. The people of Kanturk deserve better. 'Sinn Féin has consistently called for investment in rural healthcare infrastructure and this delay highlights the ongoing failure to deliver for communities outside the major urban centres. It is yet another example of rural areas being left behind. We need answers and we need action,' she added. Speaking in the Seanad on Tuesday, April 29, Senator Ryan said the proposed facility was envisioned to provide essential services including GP consultations, mental health supports and ancillary healthcare services to the community. 'The Kanturk community have been waiting for improved healthcare infrastructure since the planning permission was granted in 2018. The situation underscores a broader issue and that is the persistent neglect of rural healthcare development. While urban centres see rapid progress in healthcare projects, rural communities like Kanturk face repeated delays and setbacks.' Senator Ryan subsequently requested time for a debate with Minister Carroll MacNeill to help identify a clear timeline for progress. 'I am requesting that we allocate time for a debate with the Minister of Health. We need to understand the reasons behind the developers withdrawal, the anticipated timeline for the retendering and the measures being taken to prevent such occurrences happening in other areas in the future. 'It is imperative that we ensure that rural communities across Ireland have the same kind of commitment resources that all urban areas have,' she added.
BBC News
29-04-2025
- Health
- BBC News
'Ongoing progress' in Guernsey's mental health strategy report
Guernsey's Mental Health and Wellbeing Strategy is seeing "ongoing progress" being made, the States its 2024 annual report, which was released on Tuesday, the States said the development of a mental health and wellbeing services directory was part of work taking strategy was approved two years ago in collaboration with the States of Guernsey, Primary Care and the charitable sector, and will continue until Marc Leadbeater, Chair of the Mental Health and Wellbeing Technical Team, said he was pleased with the progress highlighted in the first full annual report. 'Clear and accessible' The States said the strategy was made up of four pillars of work, including collating bailiwick datasets, early intervention, service improvements, and responding to recommendations of external said: "Work has begun to develop a directory of mental health and wellbeing services, as well as map an island-wide network of care pathways. "Once complete, the resources will provide clear and accessible information so residents can better understand how to navigate local mental health and wellbeing services, and understand the support that is available to them. "Alongside this project, work remains ongoing to develop information and guidance for people to safely access formally accredited private therapy on-island."The report showed the overall mental health strategy to be 42% complete, with 78% of actions started and 11% of actions Leadbetter said: "I am very pleased with the publication of the first full annual report on the Mental Health and Wellbeing Strategy, which highlights our progress made since its launch in September 2023. "I would like to thank all members of the technical team and supporting officers for their dedication and hard work in helping design and implement the strategy."
Yahoo
03-03-2025
- Health
- Yahoo
Sugar Land Direct Primary Care Doctor, Dr. Adelola Ashaye, Unveils New Comprehensive Website for InTouch Primary Care
Dr. Adelola Ashaye unveils a newly designed website for InTouch Primary Care, enhancing accessibility to personalized, patient-centered healthcare for individuals, families, and small businesses. SUGAR LAND, Texas, March 3, 2025 /PRNewswire/ -- Dr. Adelola Ashaye, a double board-certified Family and Lifestyle Medicine Physician, is excited to announce the launch of the new and improved website for InTouch Primary Care. The newly designed website, provides a seamless and informative experience for patients seeking personalized and accessible primary care in Sugar Land, Missouri City, and beyond. The enhanced website serves as a vital resource for individuals, families, and small businesses exploring Direct Primary Care (DPC), an innovative healthcare model that eliminates insurance barriers and prioritizes high-quality, affordable care. With a focus on transparency, convenience, and patient-centered care, InTouch Primary Care's website offers detailed information on its membership plans, comprehensive services, and wellness-focused approach to healthcare. A New Standard for Personalized Healthcare The website highlights InTouch Primary Care's commitment to holistic and patient-focused medicine, offering a variety of services, including: Preventive Health Services – Routine checkups, screenings, and proactive wellness strategies. Chronic Disease Management – Expert treatment for diabetes, hypertension, asthma, and other conditions. Lifestyle Medicine – Weight management, nutrition, fitness, and stress management programs tailored to individual health goals. Urgent & Acute Care – Same-day and next business day appointments for immediate medical needs. Immigration Physicals - Seamless, efficient, and accurate immigration medical exams with a quick turnaround. Allergy Testing & Treatment – Identify root cause and prevent flare-ups with sublingual immunotherapy (allergy drops) a needle-free alternative to allergy shots. Why Choose Direct Primary Care? The website educates visitors on the benefits of Direct Primary Care, where patients receive: Unhurried Appointments – Quality time with a trusted physician. Easy Access to Care – Direct communication with Dr. Ashaye via phone, email, or text. Transparent Pricing – A flat membership fee with no co-pays or hidden charges. Comprehensive Wellness Support – A focus on reducing medication dependence through preventive and lifestyle-based care. Meet Dr. Adelola Ashaye Recognized as one of Houstonia Magazine's Top Doctors in Family Medicine, Dr. Ashaye brings compassion, expertise, and a commitment to transforming healthcare through her patient-first philosophy. Her new website enhances accessibility, making it easier for patients to learn about InTouch Primary Care's unique approach and schedule visits online. "Our goal with this new website is to simplify the healthcare experience and make it easier for individuals and families to access the quality care they deserve," said Dr. Ashaye. "We are excited to provide a resource that truly reflects our mission—offering personalized, affordable, and compassionate medical care without the complexities of traditional insurance-based models." A Commitment to Sugar Land & Missouri City With the launch of this new website, InTouch Primary Care reaffirms its dedication to providing high-quality, personalized healthcare to individuals and businesses in Sugar Land, Missouri City, and the surrounding areas. The platform serves as an essential tool for patients to explore services, book appointments, and experience healthcare that is simple, convenient, and truly patient-centered. For more information, visit or contact InTouch Primary Care at (713) 280-9985. About InTouch Primary Care:InTouch Primary Care is a Direct Primary Care practice dedicated to providing personalized, transparent, and comprehensive healthcare services to individuals, families, and small businesses. Led by Dr. Adelola Ashaye, the practice prioritizes patient-centered care with a strong focus on lifestyle medicine, preventive healthcare, and chronic disease management. Media Contact:Dr. Adelola Ashaye(713) 280-9985 View original content to download multimedia: SOURCE InTouch Primary Care Sign in to access your portfolio
